Insights
Pharma supply chain insights.
Showing articles from 2026. Posts 1 to 6 of 6.
Articles from 2026
Six first moves for AI in the pharma cold chain
With AI already seeping into your pharma cold chain operations, how confident are you that the plumbing underneath can take the pressure? Here are six practical first moves, distilled from our recent industry whitepaper on real-time monitoring and AI.
Read
Why lane risk assessment is the cleanest first use case for AI in pharma
Lane risk assessment has lived inside a single annual qualification exercise for too long. The economics of revisiting that decision continuously have changed.
Read
From visibility to control: lessons from the front line of pharma supply chain resilience
In a webinar hosted 6 May, Gisli Herjolfsson, CEO of Controlant, and Ruud van der Geer, Director Global Delivery Strategy at MSD, discussed what it takes to build a supply chain that doesn't just survive disruption, but responds to it in real time. This article captures the key themes from that discussion. A recording is available on request.
Read
From dashboards to dialogue: why AI is replacing the supply chain control tower
For years, the answer to better cold chain management was ‘more dashboards.’ That era is ending, and what is replacing it looks very different.
Read
Controlant: Powering the AI workforce in pharmaceutical supply chains
Artificial intelligence in pharmaceutical supply chains is only as effective as the data it relies on. For AI to deliver real value, it must be grounded in accurate, contextual, and validated operational information. Controlant’s platform is designed with this principle at its core.
Read
From reactive to predictive: how real-time visibility is cutting risk in the life sciences cold chain
Cold Chain Insights Podcast episode featuring Adalheidur (Ada) Pálmadóttir, VP Business Development at Controlant.
ReadSee the platform working on shipments like yours
Tell us what you ship and where, and we'll show you the platform on routes and products like yours.